Transcriptomics

Dataset Information

41

Taqman miRNA Array on Murine livers with varying amounts of carbon tetrachloride induced liver fibrosis


ABSTRACT: Abstract from Knabel et al. PLoS One (2015): Fibrosis refers to the accumulation of excess extracellular matrix (ECM) components and represents a key feature of many chronic inflammatory diseases. Unfortunately, no currently available treatments specifically target this important pathogenic mechanism. MicroRNAs (miRNAs) are short, non-coding RNAs that post-transcriptionally repress target gene expression and the development of miRNA-based therapeutics is being actively pursued for a diverse array of diseases. Because a single miRNA can target multiple genes, often within the same pathway, variations in the level of individual miRNAs can potently influence disease phenotypes. Members of the miR-29 family, which include mir29a, miR-29b and miR-29c, are strong inhibitors of ECM synthesis and fibrosis-associated decreases in miR-29 have been reported in multiple organs. We observed downregulation of miR-29a/b/c in fibrotic livers of carbon tetrachloride (CCl4) treated mice as well as in isolated human hepatocytes exposed to the pro-fibrotic cytokine TGF-β. Importantly, we demonstrate that a single systemic injection of a miR-29a expressing adeno-associated virus (AAV) can prevent and even reverse histologic and biochemical evidence of fibrosis despite continued exposure to CCl4. The observed therapeutic benefits were associated with AAV transduction of hepatocytes but not hepatic stellate cells, which are the main ECM producing cells in fibroproliferative liver diseases. Our data therefore demonstrate that delivery of mir-29 to the hepatic parenchyma using a clinically relevant gene delivery platform protects injured livers against fibrosis and, given the consistent fibrosis-associated downregulation of miR-29, suggests AAV-miR-29 based therapies may be effective in treating a variety of fibroproliferative disorders. The Taqman MicroRNA Array (Taqman Array Rodent MicroRNA A Cards v2.0, ABI) was run, using manufacturer's protocols, on 3 groups of mice with varying amounts fibrotic injury. The groups include carbon tetrachloride intraperitinially injected bi-weekly for 1, 4, and 8 weeks with n=4, 3, and 2 respectively for each group. The RNA was isolated from whole liver using the MiRvana miRNA Isolation Kit (Ambion) according to manufacturer's protocols. The fold_change.txt contains the following data columns; ID_Ref: mmu-miR being quantified not-treated (FC): Fold Change compared to not-treated group using Geometric mean normalization 1 week (FC): Fold Change compared to not-treated group using Geometric mean normalization 4 weeks (FC): Fold Change compared to not-treated group using Geometric mean normalization 8 weeks (FC): Fold Change compared to not-treated group using Geometric mean normalization

ORGANISM(S): Mus musculus  

SUBMITTER: K R Clark  Kalyani Ramachandran   Michael Torbenson   Andrew M Cameron   Tyler J Creamer   Hun-Way Hwang   Farooq Sheikh   Sunil Karhadkar   Daniel S Warren   Joshua T Mendell   Robert A Montgomery   Matthew K Knabel   Raghu R Chivukula    

PROVIDER: E-GEOD-66278 | ArrayExpress | 2015-02-27

SECONDARY ACCESSION(S): GSE66278PRJNA276310

REPOSITORIES: GEO, ArrayExpress

altmetric image

Publications

Sorry, this publication's infomation has not been loaded in the Indexer, please go directly to PUBMED or Altmetric.

Similar Datasets

| GSE89633 | GEO
2014-06-02 | E-GEOD-27430 | ArrayExpress
| GSE27430 | GEO
2015-09-02 | E-GEOD-15205 | ArrayExpress
2010-03-11 | GSE15205 | GEO
2014-06-02 | E-GEOD-34818 | ArrayExpress
2013-10-07 | E-GEOD-41524 | ArrayExpress
2018-08-09 | GSE90607 | GEO
2010-03-01 | GSE18651 | GEO
2015-09-02 | E-GEOD-15205 | ExpressionAtlas